Garfinkel Doron
Center for Appropriate Medication Use in Adults.
Older People, Sheba Medical Center, Israel.
Harefuah. 2020 Sep;159(9):683-688.
Improved medical technology is associated with rapidly growing sub-populations suffering from incurable co-morbidities for prolonged periods of time before death. Although there is no evidence based medicine (EBM) proving positive benefit/risk ratios for most medications in these sub-populations, it is evident that they are attended by an increased number of specialists, each of whom add medications based on "their" guidelines. Eventually, more people suffer from inappropriate medication use and polypharmacy (IMUP); IMUP's negative medical, economic and social consequences represent the 21st-century iatrogenic pandemic. Many barriers interfere with attempts to de-prescribe: The myth "drugs=health" is a deep-rooted value; de-prescribing is automatically perceived negatively; physicians are not trained to de-prescribe; and discussing de-prescribing with the patient/family is time consuming. In an era of defensive medicine, physicians have fears of lawsuits, of patient/family's reactions, fears of not following all guideline recommendations, despite the age-related decrease in their benefit/risk ratio. Like other pandemics, combined international efforts are required in order to manage IMUP effectively. The International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP) was established and has begun sowing the seeds of global collaboration. Partnership with patients/families in decision-making is essential in geriatric-palliative ethical approaches, to overcome barriers to de-prescribing. Borrowing the language of epidemics, several approaches of "curing the infected" (reducing polypharmacy) were suggested; Israeli studies have proven improved functional, mental and cognitive status and patient/family satisfaction, following massive de-prescribing, compared with those who adhered to standard recommendations. "Immunization" (prevention), should concentrate on early education of professionals and laymen about IMUP and de-prescribing. Rational de-prescribing represents "a triple-win-win game"- improves life quality in the last years of life and has huge economic benefits.
医疗技术的进步伴随着患不治之症合并症的亚人群数量迅速增长,他们在死亡前会长期患病。尽管没有循证医学(EBM)证明大多数药物对这些亚人群有积极的效益/风险比,但很明显,为他们看病的专科医生数量增加了,每位医生都根据“自己的”指南添加药物。最终,更多的人遭受不适当用药和多重用药(IMUP)之苦;IMUP产生的负面医疗、经济和社会后果代表了21世纪的医源性大流行。许多障碍阻碍了减药的尝试:“药物=健康”的观念是一种根深蒂固的价值观;减药自动被视为负面行为;医生没有接受过减药方面的培训;与患者/家属讨论减药问题很耗时。在防御性医疗的时代,医生担心会面临诉讼、患者/家属的反应,担心不遵循所有指南建议,尽管随着年龄增长药物的效益/风险比会降低。与其他大流行一样,需要国际共同努力才能有效管理IMUP。减少不适当用药和多重用药国际小组(IGRIMUP)已经成立,并开始播下全球合作的种子。在老年姑息治疗的伦理方法中,可以与患者/家属共同做决策,以克服减药的障碍。借鉴流行病的说法,有人提出了几种“治愈感染者”(减少多重用药)的方法;以色列的研究表明,与遵循标准建议的人相比,大规模减药后,患者的功能、心理和认知状况以及患者/家属的满意度都有所提高。“免疫”(预防)应集中在对专业人员和外行进行关于IMUP和减药的早期教育上。合理减药是“三赢的游戏”——能提高生命最后几年的生活质量,还能带来巨大的经济效益。